Meflin+CAFs subsets also have a cancer-suppressing effect, and infiltration of Meflin+CAFs can inhibit the growth of xenograft tumors and is associated with a good prognosis for patients, while Meflin-deficient tumor tissue has poor differentiation and tumor progression is significant [6]. This evidence concerns the gene ISLR and cancer.